Harmony Biosciences Holdings, Inc. (HRMY)
37.87
+0.32
(+0.85%)
USD |
NASDAQ |
Jan 08, 16:00
38.49
+0.62
(+1.64%)
After-Hours: 20:00
Harmony Biosciences Holdings Market Cap: 2.181B for Jan. 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Lifecore Biomedical, Inc. | 291.11M |
| West Pharmaceutical Services, Inc. | 19.80B |
| Castle Biosciences, Inc. | 1.164B |
| Nurix Therapeutics, Inc. | 1.432B |
| Moderna, Inc. | 13.23B |
Market Cap Related Metrics
| PE Ratio | 11.93 |
| PS Ratio | 2.681 |
| PEG Ratio | 0.237 |
| Price to Book Value | 2.612 |
| Price to Free Cash Flow | 7.458 |
| Price | 37.87 |
| Earnings Yield | 8.38% |
| PEGY Ratio | 0.237 |
| Operating PE Ratio | 9.814 |
| Normalized PE Ratio | 11.93 |